Prozialeck W C, Wallace T L, Weiss B
Department of Physiology and Pharmacology, Philadelphia College of Osteopathic Medicine, Pennsylvania.
J Pharmacol Exp Ther. 1987 Oct;243(1):171-9.
Upon irradiation with UV light, chlorpromazine binds irreversibly to calmodulin and inactivates it. To determine whether this chlorpromazine-calmodulin (CPZ-CaM) complex can inhibit the actions of native calmodulin, we examined its effects on the activity of calmodulin-sensitive cyclic nucleotide phosphodiesterase from rat brain and on the Ca++-adenosine triphosphatase (ATPase) of human erythrocyte membranes. The CPZ-CaM complex was prepared by irradiating purified bovine brain calmodulin in the presence of chlorpromazine and Ca++. The sample was then dialyzed extensively to remove reversibly bound chlorpromazine and then assayed for its ability to activate calmodulin-sensitive phosphodiesterase and Ca++-ATPase, and for its ability to block the stimulatory effects of native calmodulin on these enzymes. The CPZ-CaM complex had no effect on the basal activity of either enzyme; it neither activated nor inhibited the enzymes when assayed in the absence of calmodulin. However, it affected differentially the activation of the two enzymes by native calmodulin. The CPZ-CaM complex totally inhibited calmodulin-stimulated phosphodiesterase but had no effect on the activation of the ATPase by calmodulin. Other studies showed that CPZ-CaM increased the activation constant (Ka) for the interaction of calmodulin with phosphodiesterase but did not affect the maximal activation (Vmax) of the enzyme by calmodulin. Neither calmodulin nor CPZ-CaM altered the Km for the interaction between phosphodiesterase and cyclic AMP. These results suggest that CPZ-CaM inhibits the calmodulin-induced activation of phosphodiesterase by competing with calmodulin for regulatory sites on the enzyme and not by interacting with calmodulin itself or by blocking the interaction of cyclic AMP with the enzyme.(ABSTRACT TRUNCATED AT 250 WORDS)
在紫外线照射下,氯丙嗪与钙调蛋白不可逆地结合并使其失活。为了确定这种氯丙嗪 - 钙调蛋白(CPZ - CaM)复合物是否能抑制天然钙调蛋白的作用,我们研究了其对大鼠脑钙调蛋白敏感的环核苷酸磷酸二酯酶活性以及人红细胞膜钙离子 - 三磷酸腺苷酶(ATP酶)的影响。CPZ - CaM复合物是通过在氯丙嗪和钙离子存在的情况下照射纯化的牛脑钙调蛋白制备的。然后将样品进行广泛透析以去除可逆结合的氯丙嗪,接着检测其激活钙调蛋白敏感磷酸二酯酶和钙离子 - ATP酶的能力,以及阻断天然钙调蛋白对这些酶刺激作用的能力。CPZ - CaM复合物对两种酶的基础活性均无影响;在无钙调蛋白的情况下检测时,它既不激活也不抑制这些酶。然而,它对天然钙调蛋白对这两种酶的激活作用有不同影响。CPZ - CaM复合物完全抑制钙调蛋白刺激的磷酸二酯酶,但对钙调蛋白激活ATP酶没有影响。其他研究表明,CPZ - CaM增加了钙调蛋白与磷酸二酯酶相互作用的激活常数(Ka),但不影响钙调蛋白对该酶的最大激活作用(Vmax)。钙调蛋白和CPZ - CaM均未改变磷酸二酯酶与环磷酸腺苷相互作用的米氏常数(Km)。这些结果表明,CPZ - CaM通过与钙调蛋白竞争酶上的调节位点来抑制钙调蛋白诱导的磷酸二酯酶激活,而不是通过与钙调蛋白本身相互作用或阻断环磷酸腺苷与酶的相互作用。(摘要截短至250字)